Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Endoscopy
|
February 14, 2014
Fatal aortogastric fistula following fully covered metal stent placement for refractory esophageal stricture
E J M van Geenen, N C M Visser, J J Bonenkamp
Thescientificworldjournal
|
March 19, 2015
Does probability guided hysteroscopy reduce costs in women investigated for postmenopausal bleeding?
M C Breijer, N van Hanegem, N C M Visser, et al.
International Journal of Surgical Oncology
|
April 2, 2016
A Structured Assessment to Decrease the Amount of Inconclusive Endometrial Biopsies in Women with Postmenopausal Bleeding
M C Breijer, N C M Visser, N van Hanegem, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2025
Surgical stage in the era of molecular profiling of endometrial cancer
J C Kasius, W Kildal, S W Vrede, et al.
Gynecologic Oncology
|
April 16, 2021
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
S W Vrede, W J van Weelden, N C M Visser, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Endoscopy
|
February 14, 2014
Fatal aortogastric fistula following fully covered metal stent placement for refractory esophageal stricture
E J M van Geenen, N C M Visser, J J Bonenkamp
Thescientificworldjournal
|
March 19, 2015
Does probability guided hysteroscopy reduce costs in women investigated for postmenopausal bleeding?
M C Breijer, N van Hanegem, N C M Visser, et al.
International Journal of Surgical Oncology
|
April 2, 2016
A Structured Assessment to Decrease the Amount of Inconclusive Endometrial Biopsies in Women with Postmenopausal Bleeding
M C Breijer, N C M Visser, N van Hanegem, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2025
Surgical stage in the era of molecular profiling of endometrial cancer
J C Kasius, W Kildal, S W Vrede, et al.
Gynecologic Oncology
|
April 16, 2021
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
S W Vrede, W J van Weelden, N C M Visser, et al.
Page
of 1